NAXS’s initial commitments
| Apax Europe VII | EUR 15m |
| Celero Capital Fund (E) | EUR 1.5m |
| Equip Capital Fund I | NOK 20m |
| JAB Consumer Fund GCB II | USD 5m |
| JAB Consumer Fund GCB III | EUR 5m |
| JAB Consumer Partners – JCP V | EUR 5m |
| Mimir Invest | SEK 50m |
| Mimir Industries | SEK 75m |
| Nordic Capital CV1 | EUR 14.65m |
| Nordic Capital X | EUR 5m |
| Nordic Capital Evo Fund I | EUR 1m |
| Valedo Partners Fund II | SEK 65m |
In addition, NAXS has commitments to 2 private equity funds that are either in dissolution process or have exited all their portfolio companies (Herkules Private Equity III and Nordic Capital VII).
Summary Financial Information
| Equity | SEK 844m |
| Equity/share | SEK 76.20 |
| PE fund investments | 68% of equity |
| Other investments | 10% of equity |
| Net cash | 22% of equity |
News
Appointment of Nikolai Jebsen as interim CEO of NAXS AB (publ)
NAXS makes an investment of EUR 1.3 million in Equip Capital SPV SCSp
NAXS AB (publ) Half-year financial report January – June 2024
Nordic Capital Evolution to acquire a majority stake in Sensio, a leading provider of care technology
Celero Capital partners with four companies to establish Opima
Reledo, where NAXS has co-invested alongside Celero Capital Fund (E) AB, partners with three additional entrepreneur-owned firms and enters Finland to strengthen its service offering and expand its geographic reach
Nordic Capital to divest Unisport to R-GOL
Nordic Capital to sell Sunrise Medical, one of the globally leading providers of assistive mobility solutions, to Platinum Equity
Glossary
Buyout
Carried Interest
Cash & cash equivalents
Cash & cash equivalents
Cash per share
Co-investment
Commitment
Current commitments
Equity per share
General Partner (GP)
IRR (internal rate of return)
J-curve
Leverage
Limited Partner (LP)
Limited Partnership
Management Fee
Net asset value
Net cash/Net debt
Portfolio company
Preferred return
ROI (return on investment)
Total assets
Total exposure to private equity fund investments
Vintage